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We evaluated the impact of the extreme environmental conditions at high altitudes in
Antarctica on health from the viewpoint of cytokines.  The subjects were 7 men who joined
an inland research party participating in the 40th Japanese Antarctic Research Expedition.
They underwent serial hematological examinations during the expedition for over 100
days at high altitudes (the highest point was 3810 m).  The serum concentration of erythro-
poietin (EPO) increased promptly, indicating its usefulness for altitude adaptation.  The
serum concentration of interleukin-6 (IL-6) increased at high altitudes, and showed 2 peaks.
Changes in IL-6 levels did not correlate with arterial oxygen tension, serum C-reactive
protein or EPO levels.  Some psychological stress and various factors may be related to
IL-6 levels.  Since the subject who suffered bone fractures had a very high concentration
of IL-6 and his symptoms of mountain sickness were severer than the others, elevation of
IL-6 may be related with mountain sickness.  All subjects remained in relatively good
health for 3 months.  It is thought that the human body can protect itself against extreme
surroundings in Antarctica.
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The average altitude of Antarctica is 2450 m;
therefore the Antarctic inland is an extremely cold
place and the air is rarefied.  Confinement to Ant-
arctica for certain periods and isolation from the
outside world produce various sources of stress
(Palinkas, 1990).  Such extreme environmental con-
ditions cause hypoxia, mountain sickness, frostbite,
depression and so on, but it is not easy to obtain data
on basic biochemical parameters.
Hypoxia stimulates vascular endothelial cells,
leukocytes and macrophages in vitro to release pro-
inflammatory cytokines (Yan et al., 1995; Naldini
et al., 1997).  Interleukin-6 (IL-6) is a mediator of
the inflammatory response and the production of
acute phase proteins (Bendtzen, 1991; Herrmann et
al., 1994; Adamik et al., 1997).  Although several
studies examined cytokines at high altitudes, their
studies examined rapid changes in IL-6 in a short
period (Klausen et al., 1997; Hartmann et al., 2000).
We evaluated the influence of such conditions
(high altitudes, hypoxia, cold, mental stress and so
on) in the long term on health from the viewpoint of
cytokines in an Antarctic inland research party.
Subjects and Methods
The subjects were 7 members of an inland research
party participating in the 40th Japanese Antarctic
Research Expedition which lasted from 1998 to
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2000.  All subjects were healthy Japanese men, and
at the beginning of this study, their mean age was
33.7 ± 5.0 years (ranges 27 to 40).  Although one of
them (Subject X) broke his right 2nd, 3rd and 4th
metatarsal bones after the 1st blood sampling, these
fractures healed under conservative therapy, and he
could join this group.  The subjects gave informed
consent, and the experimental protocol was approv-
ed by the Headquarters of Japanese Antarctic Re-
search Expedition and National Institute of Polar
Research, Japan.
The subjects split up and set off in 4 large
snow vehicles measureing 3.5 × 7 m.  The party left
Showa Station (69˚00'S, 39˚35'E, 29 m above sea
level), the Japanese Antarctic base, on November 1,
1999, and took 4 weeks to Dome Fuji Station (77˚-
19'S, 39˚42'E, 3810 m), the Japanese Antarctic in-
land base.  They began to survey after 2 weeks of
their stay at Dome Fuji Station, and returned to
Showa Station on February 11, 2000.  In these areas
the sun does not set in December and January be-
cause of the high southern latitude.  The following
was their daily work schedule.  The subjects got up
at 0600, had a 3 regular balanced meals a day and
went to bed at 2200.  They drove snow vehicles
about 50 km in 6 h and did outdoor work for short
periods, 10 to 30 min, several times a day.  The
normal temperature inside the vehicles was about
20˚C, but only –10˚C in early morning since their
vehicles had not been warmed up yet.
Arterial blood was sampled indoors or within
the snow vehicles (20˚C) at the following points:
A, Showa Station 1 month before departure; B, at a
3032-m altitude 15 days after the start of the expedi-
tion; C, Dome Fuji station on Day 34 (Day 1, the
departure day); D, at 2960 m on Day 53; E, at 2077
m on Day 65; F, Showa Station 5 days after their
return.  The atmospheric pressure and outside tem-
perature at each blood sampling point are shown in
Table 1.
We measured the levels of Hb, red blood cell
(RBC) count and serum erythropoietin (EPO) as the
indexes of hematological adaptation to hypoxia.
Serum levels of C-reactive protein (CRP) and IL-6
were measured as the indexes of inflammation and
stress, respectively.  We measured arterial oxygen
tension (PaO2), Hb and RBC count by a portable
clinical analyzer, i-STAT (i-STAT Co., East Windsor,
NJ), and a microscope, as soon as the blood was
sampled.  Serum samples were then immediately
frozen at –20˚C and stored at –80˚C after the ex-
pedition until analysis.  The serum CRP level was
measured by latex agglutination immunoassay,
serum EPO level by radioimmunoassay and  serum
IL-6 level by chemiluminescent enzyme immuno-
assay.  By use of a modified van Beaumont formula
(Dill and Costill, 1975), calculations were made of
the % change in plasma volume from the initial
point to each point.
Moreover, the occurrence of mountain sick-
ness during the expedition was investigated.  Symp-
toms of mountain sickness observed were head-
ache, gastrointestinal symptoms (anorexia, nausea
or vomiting), fatigue or weakness, dizziness or light-
headedness and difficulty in sleeping, which were
quantified on the basis of the Lake Louise consen-
sus on the definition of altitude illness (Roach et al.,
1993).  In counting the severity of each symptom, 1
point was given for mild involvement, 2 points for
moderate, 3 points for severe and 4 points for ex-
treme involvement.  The mountain sickness score
was taken as the sum of the points.
Intergroup differences were examined by
analysis of variance.  Relationships among vari-
ables were ascertained by Spearman’s correlation
coefficient by the rank sum test.  Differences were
considered statistically significant at P < 0.05.
Results
The PaO2 decreased significantly as the atmospher-
ic pressure gradually decreased, showing a positive
correlation (r = 0.92, P < 0.001).  At the start of the
expedition, the serum concentration of EPO in-
creased significantly (48.1 ± 25.0 mU/mL, normal
level 8 to 36 mU/mL), while the RBC count in-
creased later, after the peak of EPO.  The Hb levels
peaked at Point E, after the peak of the RBC count.
There was no significant change in serum CRP dur-
ing this period (Table 1).
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The time changes in serum concentration of
IL-6 are illustrated in Table 2.  Except for Subject
X, serum concentrations of IL-6 were within nor-
mal ranges (< 4.0 pg/mL) 1 month before departure
(Point A).  The levels then rose significantly higher
than the initial Point-A level (0.58 ± 0.15 pg/mL) at
Point B (1.28 ± 0.45 pg/mL, P < 0.05), and returned
to nearly the initial level at Point F (0.57 ± 0.27 pg/
mL).  The highest serum IL-6 level was found at
Point E (1.38 ± 0.89 pg/mL), which was significant-
ly higher than at Points A and F (P < 0.05 and P <
0.01).  The plasma volumes decreased by an
average of 9%, 22%, 32%, 34% and 19% at Points
B, C, D, E and F, respectively.  Thereby the mean
serum IL-6 at each point was overestimated by 9%,
28%, 43%, 48% and 21%, respectively.  However,
Table 1.  Climate and clinical parameters at different determination points
                   Blood-sampling point
A B C D E F
Time after departure (day) – 15 34 53 65 108
Altitude above sea level (m) 29 3,032 3,810 2,960 2,077 29
Atmospheric pressure (hPa) 974.9 657.9 585.1 666.1 732.7 982.5
Air temperature (˚C) –14.6 –34.2 –41.7  –25.3 –19.2 –2.3
PaO2 (mmHg) 86.1 ±13.7 49.9 ± 3.8 44.3 ± 5.3 57.3 ± 5.1 62.6 ± 2.6 93.3 ± 8.0
EPO (mU/mL) 20.3 ± 7.7 48.1±25.0     38.5 ±23.1 16.2 ± 5.3 16.5 ± 4.5 14.5 ± 6.5
RBC (× 104/µL) 463 ± 52 484 ± 66 567 ± 75 551 ± 65 513 ± 48 497 ± 51
Hb (mg/dL) 14.5 ± 1.6 15.6 ± 0.5 16.9 ± 0.9 17.9 ± 1.5 18.0 ± 1.0 16.3 ± 1.2
CRP (mg/dL) 0.1 ± 0.1 0.1 ± 0.2 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0   0.0 ± 0.0
Mountain sickness score — 1.6 ± 1.3 0.7 ± 0.8 0.1 ± 0.4 0.0 ± 0.0  —
Number of subjects, 7.
All results are shown as mean ± SD.
A–F, see the text.
CRP, C-reactive protein; EPO, erythropoietin; PaO2, arterial oxygen tension; RBC, red blood cell.
  * P < 0.05.
** P < 0.01.
*
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even with corrections for hemoconcentration, the
IL-6 level at Point B would be higher than those at
Points A, D and F (P < 0.05, P < 0.05 and P < 0.01,
respectively).  The value of IL-6 at Point E would
still be higher than at Point F (P < 0.05).  Subject X
had a very high concentration of IL-6 at every
determination point; the values at Points A to F
were 36.2, 103.0, 56.8, 44.6, 45.4 and 36.7 pg/mL,
respectively.
Mild mountain sickness was observed in 5 of
the men 2 weeks after departure.  Although 4 of
them showed symptoms of exposure to cold, such
as headache, nasal congestion and fatigue, they re-
covered within 2 to 10 days.  However, Subject X
showed unusual headache and general fatigue per-
sisted for 6 weeks.
The concentration of IL-6 did not correlate
with the PaO2 (r = –0.28, P = 0.07), EPO level (r =
0.04, P = 0.79) and mountain sickness score (r =
0.28, P = 0.08).
Discussion
Cold, low pressure and low oxygen are known to
affect human physiology at high altitudes.  Among
these factors, low oxygen is considered to be the
most important.  In this study, we observed that the
serum concentration of EPO promptly increased:
this reaction, we thought, was necessary for humans
to adapt to a high altitude.  Since the number of
erythrocytes peaked within 6 weeks, one may con-
clude that hematological adaptation to a high alti-
tude is completed in several weeks (Wilkerson,
1975).
The concentrations of IL-6 at Points B and E
were higher than those at a low altitude.  It is known
that hypoxia increases serum IL-6 (Klausen et al.,
1997; Hartmann et al., 2000).  Klausen et al. (1997)
reported that the values of serum IL-6 were related
to arterial blood oxygen saturation and EPO values,
with rapidly reacting changes in a short period.  We
could not examine early changes in cytokines be-
cause of other various inland research and a strict
work schedule.  In our long-term observation, the
serum concentration of IL-6 was not related to
serum EPO and hypoxemia.  Since the concentra-
tion of IL-6 did not correlate with the PaO2 in this
study, factors other than low oxygen may also con-
tribute to this change.  Changes in serum CRP were
very slight, and therefore, inflammation might have
no association with changes in IL-6.
Cold itself was determined to have had little
influence on results because the subjects spent most
of their time within the snow vehicles, which were
heated.  We thought that cold in this study was a
Table 2.  Changes in the serum concentration of IL-6
                   Blood-sampling point
A B C D E F
IL-6 (pg/mL) 0.58 ± 0.15 1.28 ± 0.45 1.03 ± 0.54 0.95 ± 0.45 1.38 ± 0.89 0.57 ± 0.27
Corrected IL-6† (pg/mL) 0.58 ± 0.15 1.18 ± 0.50 0.81 ± 0.47 0.67 ± 0.33 0.94 ± 0.65 0.47 ± 0.23
Number of subjects, 6, excepting for one who suffered the bone fractures.
All results are shown as mean ± SD.
  † The level of IL-6 after correction for hemoconcentration.
A–F, see the text.
IL-6, interleukin-6.
  * P < 0.05.
** P < 0.01.
**
* *
* **
**
** *
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temporary stimulus, and one of psycholgical stres-
sors.  Several studies examined that psychological
stress is associated with an increase in serum con-
centration of IL-6 (Maes et al., 1999; Song et al.,
1999).  It has been reported that the restrain stress
increased the plasma concentrations of IL-6 in mice
(Nukina et al., 1988).  Lantis (1968) observed that
the social environment of polar regions would com-
prise a more potent source of stress than the physi-
cal environment.  In our study, the serum concen-
tration of IL-6 increased again after hematological
adaptation to the altitude was assumed to be com-
pleted.  Although we could not estimate the mental
conditions of the subjects objectively, psychologi-
cal stress under such conditions may also have con-
tributed to the increase of IL-6.
The changes in IL-6 were slight in general; in
Subject X, however, IL-6 remarkably increased
during the trip.  The fractures he suffered before
departure and a kind of posttraumatic stress dis-
order (Maes et al., 1999) in addition to hypoxia
were thought to be the reasons for this change.  On
the other hand, since his symptoms of mountain
sickness were severer than in the others, elevation
of IL-6 may be related to mountain sickness.
We were unable to identify any background
factor that might explain why the serum concen-
tration of IL-6 changed in this research.  However,
none of the subjects suffered from severe mountain
sickness like pulmonary and brain edema because
of the slow rise in altitude.  All subjects remained in
relatively good health for 3 months:  the human
body is proof that humans can survive in extreme
environmental conditions in Antarctica and accli-
mating to such surroundings is possible.
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